Philip Liang - Feb 6, 2023 Form 4/A - Amendment Insider Report for Vicarious Surgical Inc. (RBOT)

Role
Director
Signature
/s/ June Morris, Attorney-in-Fact
Stock symbol
RBOT
Transactions as of
Feb 6, 2023
Transactions value $
$81,774
Form type
4/A - Amendment
Date filed
2/9/2023, 05:30 PM
Date Of Original Report
Feb 8, 2023
Previous filing
Jan 4, 2023
Next filing
Feb 9, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RBOT Class A Common Stock Purchase $81.8K +26.8K $3.05 26.8K Feb 6, 2023 By E15 Fund III, LP F1, F2, F3
holding RBOT Class A Common Stock 43.9K Feb 6, 2023 By Chelvey International Limited F4
holding RBOT Class A Common Stock 330K Feb 6, 2023 By E15 Fund Advisors (HK) Limited F5
holding RBOT Class A Common Stock 1.19M Feb 6, 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person's purchase of the Issuer's Class A common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended. The Reporting Person has agreed to pay to the Issuer, upon confirmation of settlement of the transaction, the full amount of the profit realized in connection with the transaction.
F2 This figure is the weighted average sales price of multiple trades ranging from $3.02 to $3.0609 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.
F3 Shares held directly by E15 Fund III, LP. The Reporting Person, as the managing partner of E15 Fund III, LP, may be deemed to share voting and dispositive power over the shares held by E15 Fund III, LP. The Reporting Person disclaims beneficial ownership of shares held by E15 Fund III, LP, except to the extent of any pecuniary interest therein.
F4 Shares held directly by Chelvey International Limited. E15 Fund II, LP, the sole shareholder of Chelvey International Limited, may be deemed to have sole voting and dispositive power over the shares held by Chelvey International Limited. The Reporting Person, as the managing partner of E15 Fund II, LP, may be deemed to share voting and dispositive power over the shares held by E15 Fund II, LP. The Reporting Person disclaims beneficial ownership of shares held by E15 Fund II, LP, except to the extent of any pecuniary interest therein.
F5 Shares held directly by E15 Fund Advisors (HK) Limited. The Reporting Person, as the managing partner of E15 Fund Advisors (HK) Limited, may be deemed to share voting and dispositive power over the shares held by E15 Fund Advisors (HK) Limited. The Reporting Person disclaims beneficial ownership of shares held by E15 Fund Advisors (HK) Limited, except to the extent of any pecuniary interest therein.

Remarks:

On February 8, 2023, the Reporting Person filed a Form 4 which inadvertently reported a transaction directly by the Reporting Person. In fact, the reported transaction was by E15 Fund III, LP, an entity affiliated with the Reporting Person, as reported in this amendment. This Form 4 amendment is intended to replace, in its entirety, the Form 4 filed on February 8, 2023.